Clinical Trial Update: Substrate Modification in Stable Ventricular Tachycardia in Addition to Implantable Cardioverter Defibrillator (ICD) Therapy [NA]

View source ↗

Summary

A completed clinical trial update examines substrate modification as an adjunct to implantable cardioverter-defibrillator therapy for patients with stable ventr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease
• Left Ventricular Dysfunction
• Ventricular Tachycardia

Snippet

Sponsor: Abbott Medical Devices | Conditions: Ventricular Tachycardia, Coronary Artery Disease | NA | Status: COMPLETED